Zobrazeno 1 - 10
of 531
pro vyhledávání: '"seroprotection"'
Autor:
Francisco Noé Fonseca, Vanessa Haach, Franciana Volpato Bellaver, Gabrielly Bombassaro, Danielle Gava, Luciano Paulino da Silva, Lana Flavia Baron, Mayara Simonelly, Wanessa Araújo Carvalho, Rejane Schaefer, Ana Paula Bastos
Publikováno v:
Virology Journal, Vol 20, Iss 1, Pp 1-16 (2023)
Abstract Background Influenza A virus (IAV) causes respiratory disease in pigs and is a major concern for public health. Vaccination of pigs is the most successful measure to mitigate the impact of the disease in the herds. Influenza-based virosome i
Externí odkaz:
https://doaj.org/article/b7a3234aae484d0482559ba1dd3c3dae
Autor:
Mayuri Gogoi, Christopher A. Martin, Paul W. Bird, Martin J. Wiselka, Judi Gardener, Kate Ellis, Valerie Renals, Adam J. Lewszuk, Sally Hargreaves, Manish Pareek
Publikováno v:
Journal of Migration and Health, Vol 9, Iss , Pp 100217- (2024)
Background: Vaccine preventable diseases (VPDs) such as measles and rubella cause significant morbidity and mortality globally every year. The World Health Organization (WHO), reported vaccine coverage for both measles and rubella to be 71 % in 2019,
Externí odkaz:
https://doaj.org/article/a2d3d709423d4c65b44b3ba999588595
Publikováno v:
Expert Review of Vaccines, Vol 0, Iss 0 (2023)
Introduction Hepatitis B remains a major cause of death and morbidity worldwide. Universal childhood immunization programs have been very successful, but many adults remain unprotected or are not optimally protected. PreHevbrio [Hepatitis B Vaccine (
Externí odkaz:
https://doaj.org/article/cee557bdc1b7433d9c477f1afe2ac054
Autor:
Kuan-Yin Lin, Hsin-Yun Sun, Yu-Shan Huang, Wang-Da Liu, Szu-Min Hsieh, Sung-Hsi Huang, Guan-Jhou Chen, Chien-Ching Hung
Publikováno v:
Emerging Microbes and Infections, Vol 12, Iss 2 (2023)
Serologic responses to hepatitis A virus (HAV) vaccination may wane among immunocompromised populations. To evaluate the long-term seroresponses to 2-dose HAV vaccination, we retrospectively included people living with HIV (PLWH) who had achieved ser
Externí odkaz:
https://doaj.org/article/074f8836564f4dbab24743ea7eea9b05
Publikováno v:
Vaccine: X, Vol 14, Iss , Pp 100294- (2023)
Introduction: Hepatitis B Virus (HBV) infection is an important occupational hazard to Health Care Workers (HCWs) all over the world. International health organizations have strongly recommended the use of the HBV vaccine, especially among individual
Externí odkaz:
https://doaj.org/article/2c13862e9f494bb4aaf142e1afcc27e3
Autor:
Roseane P. Medeiros, Norah A. Terrault, Daniel F. Mazo, Claudia P. Oliveira, Jennifer Dodge, Patricia M. Zitelli, Marta H. Lopes, Flair J. Carrilho, Mário G. Pessoa
Publikováno v:
Annals of Hepatology, Vol 28, Iss 2, Pp 100891- (2023)
Introduction and Objectives: Some studies suggest chronic HCV infection diminishes responses to the anti-HBV vaccine. We evaluated the efficacy of double versus standard dose HBV vaccination among HCV patients without cirrhosis. Patients and Methods:
Externí odkaz:
https://doaj.org/article/80f3449233ee458d896c0bc3c5ea0f81
Autor:
Markus Knuf, Mika Rämet, Nina Breinholt Stærke, Isabelle Bertrand-Gerentes, Yaël Thollot, Siham B'Chir, Habiba Arroum, Philipp Oster
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 5 (2022)
MenACYW-TT (MenQuadfi®) is a quadrivalent meningococcal tetanus toxoid conjugate vaccine licensed in Europe for use in individuals ≥12 months. This study assessed whether serogroup C immune responses with MenACYW-TT were at least non-inferior, or
Externí odkaz:
https://doaj.org/article/f8fdf994f438443daff54e11407cc4ab
Publikováno v:
International Journal of Medical Arts, Vol 3, Iss 3, Pp 1748-1753 (2021)
Background:"Type 1 diabetes mellitus [T1DM]" is the most common endocrine disease in the Pediatric population. It has been suggested that T1DM had inadequate immunological response to vaccines, including hepatitis B virus [HBV] vaccine. Aim of the Wo
Externí odkaz:
https://doaj.org/article/bd25e20f301749aaa7ddd3b95d8ead09
Autor:
Yongji Wang, Yangyang Qi, Wenguo Xu, Yuansheng Hu, Ling Wang, Yongpei Yu, Zhiwei Jiang, Jielai Xia, Gang Zeng, Yalong Wang
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 10, Pp 2559-2564 (2020)
Background: Hepatitis A vaccine has been used in mass and routine public vaccination programs in China. Long-term follow-up studies are required to determine the duration of protection and the need for booster vaccinations. Methods: A prospective, ra
Externí odkaz:
https://doaj.org/article/003095164e794b2faf3325b126d1087b
Autor:
Ehsan Qadir, Qudratullah Malik, Muhammad Zahid, Ali Raza, Sajid Ali Shah, Syed Saddam Hussain
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 70, Iss 5, Pp 1349-1353 (2020)
Objective: To compare seroprotection of children at 5 and 6 year of age after receiving Hepatitis B vaccination according to Expanded Programme on Immunization (EPI). Study Design: Cross sectional study. Place and Duration of Study: The study w
Externí odkaz:
https://doaj.org/article/9e54e632cd19493abba465bb9a8c76f6